Search
for
Sort by
Research 481–510 of 1000+
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Overview of Alopecia Areata
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Efficacy and safety of methotrexate in alopecia areata
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata
- Cardiovascular Disease-Associated Skin Conditions
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Systemic humoral activation facilitates tissue regeneration by D-chiral biomaterial scaffolds
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- A study of serum prolactin in dermatological diseases in a tertiary care hospital of Assam
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Mite Burden and Immunophenotypic Response to <i>Demodex musculi</i> in Swiss Webster, BALB/c, C57BL/6, and NSG Mice
- Impact of Vitamin D on Immunopathology of Hashimoto’s Thyroiditis: From Theory to Practice
- Possible Immunomodulating Effect of Retinol on Cytokines Secretion in Patients with Recurrent Furunculosis
- Topical calcipotriol mixed with topical steroid versus topical steroid alone in treatment of alopecia areata
- Vaccines, adjuvants and autoimmunity
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Natural killer cells in atopic and autoimmune diseases of the skin
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma